Cozaar (losartan) for preventing stroke
Merck will now promote Cozaar (losartan) for preventing stroke.
FDA just approved this new indication for patients with hypertension and left ventricular hypertrophy.
These patients have about twice the risk for stroke compared to patients without left ventricular hypertrophy.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote